Completed PHASE4 INTERVENTIONAL 2-arm NCT00826670

Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study

Sponsor: University Hospital, Geneva

Conditions Enterobacteriaceae Infections

Interventions Decolonization Placebo (Decolonization)

Updated 5 times since 2017 Last updated: Aug 6, 2012 Started: Jun 30, 2009 Primary completion: Aug 31, 2012 Completion: Aug 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00826670, this PHASE4 trial focuses on Enterobacteriaceae Infections and remains completed. Sponsored by University Hospital, Geneva, it has been updated 5 times since 2009, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Geneva

Data source: University Hospital, Geneva

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Geneva, Switzerland